论文部分内容阅读
目的 :探讨稀释法自体输血在喉癌手术中的应用价值。方法 :对 30例 、 期喉癌患者采用稀释法自体输血 (稀释组 ) ,仅在术中失血过多时 ,再输入适量异体血 ;将 30例病情及手术方法与稀释组一致的喉癌患者为对照组 ,不采用稀释法自体输血 ,有输血指征时输入异体血。结果 :稀释组中仅 8例需输入异体血 ,对照组中 1 9例需输入异体血 ,差异有极显著性意义 (P <0 .0 1 ) ;两组均无并发症发生 (P >0 .0 5)。结论 :稀释法自体输血可使许多需手术治疗的晚期喉癌患者避免异体输血
Objective: To explore the value of dilution method autologous blood transfusion in laryngeal cancer surgery. Methods: Thirty patients with laryngeal cancer were treated with dilution blood transfusions (dilution group), and only when the blood loss was excessive, allogeneic blood was injected. Thirty patients with laryngeal carcinoma whose disease and operation method were consistent with the dilution group were The control group, do not use the dilution method of autologous blood transfusion, blood transfusion indicators input allogeneic blood. Results: Only 8 cases of allogeneic blood were needed in the dilution group, and allogeneic blood was needed in the control group (P <0.01). There was no complication in both groups (P> 0) .0 5). CONCLUSIONS: Dilution autologous blood transfusion allows many patients with advanced laryngeal cancer requiring surgical treatment to avoid allogenic transfusion